Sensitive and Specific Detection of Breast Cancer Lymph Node Metastasis Through Dual-modality Magnetic Particle Imaging and Fluorescence Molecular Imaging: a Preclinical Evaluation

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2022 May 19

PMID 35590110

Authors

Guorong Wang

Wenzhe Li

Guangyuan Shi

Yu Tian

Lingyan Kong

Ning Ding

Jing Lei

Zhengyu Jin

Jie Tian

Yang Du

Affiliations

Soon will be listed here.

Abstract

Purpose: A sensitive and specific imaging method to detect metastatic cancer cells in lymph nodes to detect the early-stage breast cancer is still a challenge. The purpose of this study was to investigate a novel breast cancer-targeting and tumour microenvironment ATP-responsive superparamagnetic iron oxide nanoparticles (SPIOs) imaging probe (abbreviated as SPIOs@A-T) that was developed to detect lymph node metastasis through fluorescence molecular imaging (FMI) and magnetic particle imaging (MPI).

Methods: The conjugation of the targeted peptide CREKA and SPIOs was via linker sulfo-SMCC, while the dsDNA-Cy5.5 was modified on SPIOs through the conjugation between maleimide group in sulfo-SMCC and sulfydryl group in dsDNA-Cy5.5. SPIOs@A-T was characterised for its imaging properties, targeting ability and toxicity in vitro. Mice with metastatic lymph node (MLN) of breast cancer were established to evaluate the FMI and MPI imaging strategy in vivo. Healthy mice with normal lymph node (NLN) were used as control group. Histological examination and biosafety evaluation were performed for further assessment.

Results: After injection with SPIOs@A-T, the obvious high fluorescent intensity and MPI signal were observed in MLN group than those in NLN group. FMI can specifically light up MLN using an ATP-responsive fluorescence design. On the other hand, MPI could complement the limitation of imaging depth from FMI and could detect MLN more sensitively. Besides, the biosafety evaluation results showed SPIOs@A-T had no detectable biological toxicity.

Conclusion: SPIOs@A-T imaging probe in combination with FMI and MPI can provide a promising novel method for the precise detection of MLN in vivo.

Citing Articles

Advances in molecular imaging and targeted therapeutics for lymph node metastasis in cancer: a comprehensive review.

Wu Y, Shang J, Zhang X, Li N J Nanobiotechnology. 2024; 22(1):783.

PMID: 39702277 PMC: 11657939. DOI: 10.1186/s12951-024-02940-4.

Surface Engineering of Magnetic Iron Oxide Nanoparticles for Breast Cancer Diagnostics and Drug Delivery.

Xie M, Meng F, Wang P, Diaz-Garcia A, Parkhats M, Santos-Oliveira R Int J Nanomedicine. 2024; 19:8437-8461.

PMID: 39170101 PMC: 11338174. DOI: 10.2147/IJN.S477652.

Emerging Applications of Nanoparticles in the Diagnosis and Treatment of Breast Cancer.

Oehler J, Rajapaksha W, Albrecht H J Pers Med. 2024; 14(7).

PMID: 39063977 PMC: 11278299. DOI: 10.3390/jpm14070723.

First magnetic particle imaging to assess pulmonary vascular leakage in vivo in the acutely injured and fibrotic lung.

Feng X, Gao P, Li Y, Hui H, Jiang J, Xie F Bioeng Transl Med. 2024; 9(2):e10626.

PMID: 38435827 PMC: 10905553. DOI: 10.1002/btm2.10626.

Glucose-Regulated Protein 78 Targeting ICG and DOX Loaded Hollow FeO Nanoparticles for Hepatocellular Carcinoma Diagnosis and Therapy.

Jin Y, Cheng Z, Yuan Z, Du Y, Tian J, Shao B Int J Nanomedicine. 2024; 19:189-208.

PMID: 38223882 PMC: 10785830. DOI: 10.2147/IJN.S428687.

References

Gong Z, Chen M, Ren Q, Yue X, Dai Z . Fibronectin-targeted dual-acting micelles for combination therapy of metastatic breast cancer. Signal Transduct Target Ther. 2020; 5(1):12. PMC: 7005157. DOI: 10.1038/s41392-019-0104-3. View

Nekolla E, Brix G, Griebel J . Lung Cancer Screening with Low-Dose CT: Radiation Risk and Benefit-Risk Assessment for Different Screening Scenarios. Diagnostics (Basel). 2022; 12(2). PMC: 8870982. DOI: 10.3390/diagnostics12020364. View

Kim H, Park W, Kim S, Ahn S, Kim Y, Kim T . Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI. Breast. 2019; 49:63-69. PMC: 7375624. DOI: 10.1016/j.breast.2019.10.017. View

Song G, Kenney M, Chen Y, Zheng X, Deng Y, Chen Z . Carbon-coated FeCo nanoparticles as sensitive magnetic-particle-imaging tracers with photothermal and magnetothermal properties. Nat Biomed Eng. 2020; 4(3):325-334. PMC: 7071985. DOI: 10.1038/s41551-019-0506-0. View

To B, Isaac D, Andrechek E . Studying Lymphatic Metastasis in Breast Cancer: Current Models, Strategies, and Clinical Perspectives. J Mammary Gland Biol Neoplasia. 2020; 25(3):191-203. DOI: 10.1007/s10911-020-09460-5. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Zou R, Gong Q, Shi Z, Zheng J, Xing J, Liu C . A ZIF-90 nanoplatform loaded with an enzyme-responsive organic small-molecule probe for imaging the hypoxia status of tumor cells. Nanoscale. 2020; 12(27):14870-14881. DOI: 10.1039/d0nr02580a. View

Chen F, Ma K, Madajewski B, Zhuang L, Zhang L, Rickert K . Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer. Nat Commun. 2018; 9(1):4141. PMC: 6175906. DOI: 10.1038/s41467-018-06271-5. View

Shiino S, Matsuzaki J, Shimomura A, Kawauchi J, Takizawa S, Sakamoto H . Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer. Clin Cancer Res. 2018; 25(6):1817-1827. DOI: 10.1158/1078-0432.CCR-18-1414. View

10.

Weber R, van Hal R, Stracke P, Hadisurya J, Nordmeyer H, Chapot R . Incidence of Acute Kidney Injury After Computed Tomography Angiography±Computed Tomography Perfusion Followed by Thrombectomy in Patients With Stroke Using a Postprocedural Hydration Protocol. J Am Heart Assoc. 2020; 9(4):e014418. PMC: 7070223. DOI: 10.1161/JAHA.119.014418. View

11.

Talebloo N, Gudi M, Robertson N, Wang P . Magnetic Particle Imaging: Current Applications in Biomedical Research. J Magn Reson Imaging. 2019; 51(6):1659-1668. DOI: 10.1002/jmri.26875. View

12.

Qian C, Chen Y, Zhu S, Yu J, Zhang L, Feng P . ATP-Responsive and Near-Infrared-Emissive Nanocarriers for Anticancer Drug Delivery and Real-Time Imaging. Theranostics. 2016; 6(7):1053-64. PMC: 4876629. DOI: 10.7150/thno.14843. View

13.

Paredes P, Vidal-Sicart S, Campos F, Tapias A, Sanchez N, Martinez S . Role of ICG-Tc-nanocolloid for sentinel lymph node detection in cervical cancer: a pilot study. Eur J Nucl Med Mol Imaging. 2017; 44(11):1853-1861. DOI: 10.1007/s00259-017-3706-4. View

14.

Engel J, Weichert W, Jung A, Emeny R, Holzel D . Lymph node infiltration, parallel metastasis and treatment success in breast cancer. Breast. 2019; 48:1-6. DOI: 10.1016/j.breast.2019.07.008. View

15.

Zhang D, Zheng Y, Lin Z, Liu X, Li J, Yang H . Equipping Natural Killer Cells with Specific Targeting and Checkpoint Blocking Aptamers for Enhanced Adoptive Immunotherapy in Solid Tumors. Angew Chem Int Ed Engl. 2020; 59(29):12022-12028. DOI: 10.1002/anie.202002145. View

16.

Cykowska A, Marano L, DIgnazio A, Marrelli D, Swierblewski M, Jaskiewicz J . New technologies in breast cancer sentinel lymph node biopsy; from the current gold standard to artificial intelligence. Surg Oncol. 2020; 34:324-335. DOI: 10.1016/j.suronc.2020.06.005. View

17.

Mitchell M, Billingsley M, Haley R, Wechsler M, Peppas N, Langer R . Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2020; 20(2):101-124. PMC: 7717100. DOI: 10.1038/s41573-020-0090-8. View

18.

Zhou F, Fu T, Huang Q, Kuai H, Mo L, Liu H . Hypoxia-Activated PEGylated Conditional Aptamer/Antibody for Cancer Imaging with Improved Specificity. J Am Chem Soc. 2019; 141(46):18421-18427. DOI: 10.1021/jacs.9b05063. View

19.

Wang Y, Jiang L, Zhang Y, Lu Y, Li J, Wang H . Fibronectin-Targeting and Cathepsin B-Activatable Theranostic Nanoprobe for MR/Fluorescence Imaging and Enhanced Photodynamic Therapy for Triple Negative Breast Cancer. ACS Appl Mater Interfaces. 2020; 12(30):33564-33574. DOI: 10.1021/acsami.0c10397. View

20.

Chandrasekharan P, Tay Z, Hensley D, Zhou X, Fung B, Colson C . Using magnetic particle imaging systems to localize and guide magnetic hyperthermia treatment: tracers, hardware, and future medical applications. Theranostics. 2020; 10(7):2965-2981. PMC: 7053197. DOI: 10.7150/thno.40858. View